ArticleJMIR research protocols2024

A Predictive Noninvasive Single-Nucleotide Variation-Based Biomarker Signature for Resectable Pancreatic Cancer: Protocol for a Prospective Validation Study.

Nico Seeger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.